{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:45:43Z","timestamp":1785822343971,"version":"3.56.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Drug Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Molecular glues are small molecules that induce ternary complexes between a protein of interest and a partner protein, creating therapeutic mechanisms distinct from traditional inhibitors. This minireview examines binding-site architectures of clinically tested molecular glues and extends these insights to ubiquitin-family partner proteins. Structural analysis suggests recurring recognition features, while emerging computational methods may accelerate discovery and optimization of ubiquitin-directed glues for therapeutic applications.<\/jats:p>","DOI":"10.1038\/s44386-026-00059-0","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:05:54Z","timestamp":1785819954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ubiquitin family as novel protein partners for molecular glues"],"prefix":"10.1038","volume":"3","author":[{"given":"Laura","family":"Silvian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"59_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0092-8674(92)90158-9","volume":"70","author":"SL Schreiber","year":"1992","unstructured":"Schreiber, S. L. Immunophilin-sensitive protein phosphatase action in cell signalling pathways. Cell 70, 365\u2013368 (1992).","journal-title":"Cell"},{"key":"59_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","volume":"184","author":"SL Schreiber","year":"2021","unstructured":"Schreiber, S. L. The rise of molecular glues. Cell 184, 3\u20139 (2021).","journal-title":"Cell"},{"key":"59_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41587-025-02779-6","volume":"43","author":"M Cully","year":"2025","unstructured":"Cully, M. Natural molecular glues spur next-gen small molecules for \u2018undruggable\u2019 targets. Nat. Biotechnol. 43, 1212\u20131214 (2025).","journal-title":"Nat. Biotechnol."},{"key":"59_CR4","doi-asserted-by":"publisher","first-page":"e202500048","DOI":"10.1002\/cmdc.202500048","volume":"20","author":"ML Repity","year":"2025","unstructured":"Repity, M. L., Deutscher, R. C. E. & Hausch, F. Nondegradative synthetic molecular glues enter the clinic. ChemMedChem 20, e202500048 (2025).","journal-title":"ChemMedChem"},{"key":"59_CR5","doi-asserted-by":"publisher","first-page":"110712","DOI":"10.1016\/j.isci.2024.110712","volume":"27","author":"X Tan","year":"2024","unstructured":"Tan, X., Huang, Z., Pei, H., Jia, Z. & Zheng, J. Molecular glue-mediated targeted protein degradation: a novel strategy in small-molecule drug development. iScience 27, 110712 (2024).","journal-title":"iScience"},{"key":"59_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1039\/D2CB00216G","volume":"4","author":"RR Stein","year":"2023","unstructured":"Stein, R. R., Fouche, M., Kearns, J. D. & Roth, H. J. A model-informed method to retrieve intrinsic from apparent cooperativity and project cellular target occupancy for ternary complex-forming compounds. RSC Chem. Biol. 4, 512\u2013523 (2023).","journal-title":"RSC Chem. Biol."},{"key":"59_CR7","doi-asserted-by":"publisher","first-page":"17195","DOI":"10.1073\/pnas.2006560117","volume":"117","author":"UK Shigdel","year":"2020","unstructured":"Shigdel, U. K. et al. Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface. Proc. Natl. Acad. Sci. USA 117, 17195\u201317203 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1006\/bbrc.1997.6307","volume":"232","author":"G Baughman","year":"1997","unstructured":"Baughman, G., Wiederrecht, G. J., Chang, F., Martin, M. M. & Bourgeois, S. Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition. Biochem. Biophys. Res. Commun. 232, 437\u2013443 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"59_CR9","unstructured":"Rusconi, P. Magnet Biomedicine Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Novel Molecular Glue Medicines, https:\/\/magnetbio.com\/ (2025)."},{"key":"59_CR10","doi-asserted-by":"publisher","first-page":"23281","DOI":"10.1021\/jacs.3c08307","volume":"145","author":"S Liu","year":"2023","unstructured":"Liu, S. et al. Rational screening for cooperativity in small-molecule inducers of protein-protein associations. J. Am. Chem. Soc. 145, 23281\u201323291 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"59_CR11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/acscentsci.3c00395","volume":"9","author":"X Liu","year":"2023","unstructured":"Liu, X. & Ciulli, A. Proximity-based modalities for biology and medicine. ACS Cent. Sci. 9, 1269\u20131284 (2023).","journal-title":"ACS Cent. Sci."},{"key":"59_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1126\/science.ady4446","volume":"389","author":"MD Hartmann","year":"2025","unstructured":"Hartmann, M. D. Expanding the reach of molecular glue degraders. Science 389, 32\u201333 (2025).","journal-title":"Science"},{"key":"59_CR13","doi-asserted-by":"publisher","first-page":"eadt6736","DOI":"10.1126\/science.adt6736","volume":"389","author":"G Petzold","year":"2025","unstructured":"Petzold, G. et al. Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition. Science 389, eadt6736 (2025).","journal-title":"Science"},{"key":"59_CR14","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/s41589-025-01936-x","volume":"21","author":"A Tutter","year":"2025","unstructured":"Tutter, A. et al. A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1. Nat. Chem. Biol. 21, 1688\u20131696 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"59_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/acscentsci.2c01317","volume":"9","author":"ES Toriki","year":"2023","unstructured":"Toriki, E. S. et al. Rational chemical design of molecular glue degraders. ACS Cent. Sci. 9, 915\u2013926 (2023).","journal-title":"ACS Cent. Sci."},{"key":"59_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1039\/D4CB00190G","volume":"6","author":"P Ghosh","year":"2024","unstructured":"Ghosh, P. et al. Discovery and design of molecular glue enhancers of CDK12-DDB1 interactions for targeted degradation of cyclin K. RSC Chem. Biol. 6, 36\u201355 (2024).","journal-title":"RSC Chem. Biol."},{"key":"59_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41589-019-0378-3","volume":"16","author":"TB Faust","year":"2020","unstructured":"Faust, T. B. et al. Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15. Nat. Chem. Biol. 16, 7\u201314 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"59_CR18","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41589-024-01668-4","volume":"20","author":"YD Li","year":"2024","unstructured":"Li, Y. D. et al. Template-assisted covalent modification underlies activity of covalent molecular glues. Nat. Chem. Biol. 20, 1640\u20131649 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"59_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-024-07089-6","volume":"627","author":"O Hsia","year":"2024","unstructured":"Hsia, O. et al. Targeted protein degradation via intramolecular bivalent glues. Nature 627, 204\u2013211 (2024).","journal-title":"Nature"},{"key":"59_CR20","doi-asserted-by":"publisher","first-page":"116904","DOI":"10.1016\/j.ejmech.2024.116904","volume":"279","author":"MM Hassan","year":"2024","unstructured":"Hassan, M. M. et al. Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues. Eur. J. Med. Chem. 279, 116904 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"59_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63594-w","volume":"16","author":"SJ Hughes","year":"2025","unstructured":"Hughes, S. J. et al. Mode of action of a DCAF16-recruiting targeted glue that can selectively degrade BRD9. Nat. Commun. 16, 8516 (2025).","journal-title":"Nat. Commun."},{"key":"59_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s43018-025-01081-3","volume":"7","author":"E Haines","year":"2026","unstructured":"Haines, E. et al. The MEK-RAF molecular glue IK-595 has potent antitumor activity across RAS\/MAPK pathway-altered cancers. Nat. Cancer 7, 116\u2013130 (2026).","journal-title":"Nat. Cancer"},{"key":"59_CR23","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/2159-8290.CD-24-0139","volume":"14","author":"MB Ryan","year":"2024","unstructured":"Ryan, M. B. et al. The Pan-RAF-MEK nondegrading molecular glue NST-628 is a potent and brain-penetrant inhibitor of the RAS-MAPK pathway with activity across diverse RAS- and RAF-driven cancers. Cancer Discov. 14, 1190\u20131205 (2024).","journal-title":"Cancer Discov."},{"key":"59_CR24","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.chembiol.2024.04.002","volume":"31","author":"M Konstantinidou","year":"2024","unstructured":"Konstantinidou, M. & Arkin, M. R. Molecular glues for protein-protein interactions: progressing toward a new dream. Cell Chem. Biol. 31, 1064\u20131088 (2024).","journal-title":"Cell Chem. Biol."},{"key":"59_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cells13050409","volume":"13","author":"M Jhanwar-Uniyal","year":"2024","unstructured":"Jhanwar-Uniyal, M. et al. Discrete mechanistic target of rapamycin signaling pathways, stem cells, and therapeutic targets. Cells 13, 409 (2024).","journal-title":"Cells"},{"key":"59_CR26","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1039\/D4SC06917J","volume":"16","author":"RCE Deutscher","year":"2025","unstructured":"Deutscher, R. C. E. et al. Discovery of fully synthetic FKBP12-mTOR molecular glues. Chem. Sci. 16, 4256\u20134263 (2025).","journal-title":"Chem. Sci."},{"key":"59_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.chembiol.2024.12.002","volume":"32","author":"ZY Tan","year":"2025","unstructured":"Tan, Z. Y. et al. Development of an FKBP12-recruiting chemical-induced proximity DNA-encoded library and its application to discover an autophagy potentiator. Cell Chem. Biol. 32, 498\u2013510.e435 (2025).","journal-title":"Cell Chem. Biol."},{"key":"59_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41557-018-0187-4","volume":"11","author":"Z Guo","year":"2019","unstructured":"Guo, Z. et al. Rapamycin-inspired macrocycles with new target specificity. Nat. Chem. 11, 254\u2013263 (2019).","journal-title":"Nat. Chem."},{"key":"59_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1126\/science.adg9652","volume":"381","author":"CJ Schulze","year":"2023","unstructured":"Schulze, C. J. et al. Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS. Science 381, 794\u2013799 (2023).","journal-title":"Science"},{"key":"59_CR30","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1021\/acs.jmedchem.4c02313","volume":"68","author":"J Cregg","year":"2025","unstructured":"Cregg, J. et al. Discovery of Elironrasib (RMC-6291), a potent and orally bioavailable, RAS(ON) G12C-selective, covalent tricomplex inhibitor for the treatment of patients with RAS G12C-addicted cancers. J. Med. Chem. 68, 6041\u20136063 (2025).","journal-title":"J. Med. Chem."},{"key":"59_CR31","doi-asserted-by":"publisher","first-page":"eads0239","DOI":"10.1126\/science.ads0239","volume":"389","author":"C Weller","year":"2025","unstructured":"Weller, C. et al. A neomorphic protein interface catalyzes covalent inhibition of RAS(G12D) aspartic acid in tumors. Science 389, eads0239 (2025).","journal-title":"Science"},{"key":"59_CR32","doi-asserted-by":"publisher","first-page":"e70132","DOI":"10.1002\/cncr.70132","volume":"131","author":"YA Anaya","year":"2025","unstructured":"Anaya, Y. A. et al. Proteolysis-targeting chimeras in cancer therapy: targeted protein degradation for next-generation treatment. Cancer 131, e70132 (2025).","journal-title":"Cancer"},{"key":"59_CR33","unstructured":"Salarius Pipeline, https:\/\/salariuspharma.com\/our-programs\/pipeline\/ (2026)."},{"key":"59_CR34","unstructured":"Pipeline, https:\/\/www.monterosatx.com\/pipeline\/ (2026)."},{"key":"59_CR35","unstructured":"Sandoz. PR Sandoz Cyclosporine, https:\/\/sandoz-ca.cms.sandoz.com\/sites\/default\/files\/Media%20Documents\/Sandoz%C2%AE%20Cyclosporine%20Monograph.pdf (2023)."},{"key":"59_CR36","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/S2666-7568(23)00258-1","volume":"5","author":"DJW Lee","year":"2024","unstructured":"Lee, D. J. W., Hodzic Kuerec, A. & Maier, A. B. Targeting ageing with rapamycin and its derivatives in humans: a systematic review. Lancet Healthy Longev. 5, e152\u2013e162 (2024).","journal-title":"Lancet Healthy Longev."},{"key":"59_CR37","unstructured":"Revolutions Medicine Pipeline, https:\/\/www.revmed.com\/pipeline\/ (2026)."},{"key":"59_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51889-3","volume":"15","author":"V Sauve","year":"2024","unstructured":"Sauve, V. et al. Activation of parkin by a molecular glue. Nat. Commun. 15, 7707 (2024).","journal-title":"Nat. Commun."},{"key":"59_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nchembio.1412","volume":"10","author":"H Huang","year":"2014","unstructured":"Huang, H. et al. E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin. Nat. Chem. Biol. 10, 156\u2013163 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"59_CR40","doi-asserted-by":"publisher","first-page":"eabi5797","DOI":"10.1126\/sciadv.abi5797","volume":"7","author":"D St-Cyr","year":"2021","unstructured":"St-Cyr, D. et al. Identification and optimization of molecular glue compounds that inhibit a noncovalent E2 enzyme-ubiquitin complex. Sci. Adv. 7, eabi5797 (2021).","journal-title":"Sci. Adv."},{"key":"59_CR41","doi-asserted-by":"publisher","unstructured":"Shi, H. et al. Orthosteric molecular glue inhibits COP9 signalosome with substrate-dependent potency. bioRxiv https:\/\/doi.org\/10.1101\/2025.11.26.690573 (2025).","DOI":"10.1101\/2025.11.26.690573"},{"key":"59_CR42","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41586-026-10129-y","volume":"652","author":"H Shi","year":"2026","unstructured":"Shi, H. et al. CSN5i-3 is an orthosteric molecular glue inhibitor of COP9 signalosome. Nature 652, 1375\u20131383 (2026).","journal-title":"Nature"},{"key":"59_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2024.12.015","volume":"85","author":"R Agrata","year":"2025","unstructured":"Agrata, R. & Komander, D. Ubiquitin\u2014a structural perspective. Mol. Cell 85, 323\u2013346 (2025).","journal-title":"Mol. Cell"},{"key":"59_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrm3919","volume":"16","author":"RI Enchev","year":"2015","unstructured":"Enchev, R. I., Schulman, B. A. & Peter, M. Protein neddylation: beyond cullin-RING ligases. Nat. Rev. Mol. Cell Biol. 16, 30\u201344 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59_CR45","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.3390\/cells10112825","volume":"10","author":"TY Yau","year":"2021","unstructured":"Yau, T. Y., Sander, W., Eidson, C. & Courey, A. J. SUMO interacting motifs: structure and function. Cells 10, 2825 (2021).","journal-title":"Cells"},{"key":"59_CR46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/EBC20253039","volume":"69","author":"A Mishra","year":"2025","unstructured":"Mishra, A., Cisse, E. H. & Suskiewicz, M. J. Non-covalent SUMO interactions with ligases and effectors: SUMO-interacting motifs and beyond. Essays Biochem 69, 323\u2013347 (2025).","journal-title":"Essays Biochem"},{"key":"59_CR47","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1002\/mco2.736","volume":"5","author":"Y Liao","year":"2024","unstructured":"Liao, Y., Zhang, W., Liu, Y., Zhu, C. & Zou, Z. The role of ubiquitination in health and disease. MedComm 5, e736 (2024).","journal-title":"MedComm"},{"key":"59_CR48","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gkaa443","volume":"48","author":"Z Li","year":"2020","unstructured":"Li, Z., Jaroszewski, L., Iyer, M., Sedova, M. & Godzik, A. FATCAT 2.0: towards a better understanding of the structural diversity of proteins. Nucleic Acids Res. 48, W60\u2013W64 (2020).","journal-title":"Nucleic Acids Res."},{"key":"59_CR49","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/ja512751q","volume":"137","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J. Am. Chem. Soc. 137, 2695\u20132703 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"59_CR50","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1039\/B608269F","volume":"8","author":"N Huang","year":"2006","unstructured":"Huang, N., Kalyanaraman, C., Bernacki, K. & Jacobson, M. P. Molecular mechanics methods for predicting protein-ligand binding. Phys. Chem. Chem. Phys. 8, 5166\u20135177 (2006).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"59_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10822-017-0058-x","volume":"32","author":"PC Lam","year":"2018","unstructured":"Lam, P. C., Abagyan, R. & Totrov, M. Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand\/receptor structure-based approach. J. Comput Aided Mol. Des. 32, 187\u2013198 (2018).","journal-title":"J. Comput Aided Mol. Des."},{"key":"59_CR52","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1021\/acs.jcim.2c01386","volume":"63","author":"DR Weiss","year":"2023","unstructured":"Weiss, D. R. et al. On ternary complex stability in protein degradation: in silico molecular glue binding affinity calculations. J. Chem. Inf. Model. 63, 2382\u20132392 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"59_CR53","doi-asserted-by":"publisher","unstructured":"Liao, Y., Zhu, J., Xie, J., Lai, L. & Pei, J. Comparative assessment of co-folding methods for molecular glue ternary structure prediction. Preprint at: https:\/\/doi.org\/10.1101\/2025.05.25.655997 (2025)","DOI":"10.1101\/2025.05.25.655997"},{"key":"59_CR54","doi-asserted-by":"publisher","unstructured":"Lukauskis, D., Kashif-Khan, N., Tame, C. & Potterton, A. Optimizing molecular glues using free energy perturbation and cofolding methods. Preprint at: https:\/\/doi.org\/10.26434\/chemrxiv-2025-tb29n (2025).","DOI":"10.26434\/chemrxiv-2025-tb29n"},{"key":"59_CR55","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41586-024-08435-4","volume":"639","author":"A Marchand","year":"2025","unstructured":"Marchand, A. et al. Targeting protein-ligand neosurfaces with a generalizable deep learning tool. Nature 639, 522\u2013531 (2025).","journal-title":"Nature"},{"key":"59_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13166","volume":"7","author":"A Schlierf","year":"2016","unstructured":"Schlierf, A. et al. Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat. Commun. 7, 13166 (2016).","journal-title":"Nat. Commun."}],"container-title":["npj Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00059-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00059-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:05:55Z","timestamp":1785819955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00059-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1038\/s44386-026-00059-0","relation":{},"ISSN":["3005-1452"],"issn-type":[{"value":"3005-1452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"25"}}